Sildenafil pill

Sildenafil pill could be effective against Alzheimer’s

A US research team have been studying the effects of Sildenafil, also known as Viagra, in the brain and have found that the drug targets some of the proteins that accumulate in Alzheimer’s dementia.

The research found that from the seven million patients in the study, men who took the drug had a lower risk of developing Alzheimer’s.

There are currently around 850,000 people with dementia in the UK and is expected to ride to 1.6 million by 2040 according to the Alzheimer’s Society.

1 every 3 minutes develop dementia

Sildenafil, improves blood flow by widening and relaxing blood vessels and whilst its primary use in current society is for erectile dysfunction in men, scientists have found it is effective in lung conditions such as pulmonary hypertension.

Research into whether the drug could also be effective in vascular dementia, the second most common form of dementia, which is caused by reduced blood flow which damages the brain.

The Cleveland team, who undertook the study, found that high doses of Viagra, larger than what the average person would take, increased brain cell growth and reduced protein accumulation in human tissue.

It also revealed that people prescribed the drug were less likely to develop Alzheimer’s than those not taking the medication.

Lead investigator Dr Feixiong Cheng said: "Because our findings only establish an association between sildenafil use and reduced incidence of Alzheimer's disease, we are now planning a mechanistic trial and a phase II randomized clinical trial to test causality and confirm sildenafil's clinical benefits for Alzheimer's patients."

UK brain research expert Prof Tara Spires-Jones, the University of Edinburgh, said: "More work will be needed to know whether this drug can indeed lower risk for Alzheimer's disease.

"While these data are interesting scientifically, based on this study, I would not rush out to start taking sildenafil as a prevention for Alzheimer's disease."

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all